Related Experiment Video
Updated: Jul 2, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
Immunophenotyping of acute lymphoblastic leukemia using immunohistochemistry in bone marrow biopsy specimens
1Section of Hematopathology, Department of Pathology, College of Medicine, King Khalid University Hospital and King Saud University Medical College, Riyadh, Kingdom of Saudi Arabia. lgwaiz@yahoo.com
Insights
Immunohistochemical staining (IH) of bone marrow biopsies can diagnose and immunophenotype acute lymphoblastic leukemia (ALL). This method is valuable when flow cytometry is not feasible, confirming ALL subtypes effectively.
Area of Science:
- Hematology
- Oncology
- Pathology
Background:
- Flow cytometry is the standard for acute lymphoblastic leukemia (ALL) diagnosis and immunophenotyping.
- Immunohistochemical staining (IH) of bone marrow trephine biopsies offers an alternative for immunophenotypic analysis.
- Evaluating the utility of IH in ALL diagnosis is crucial for situations where flow cytometry is limited.
Purpose of the Study:
- To assess the diagnostic and immunophenotyping value of IH in bone marrow trephine biopsies for acute lymphoblastic leukemia (ALL).
- To compare IH results with established methods for classifying ALL subtypes (pre-B, T, and B ALL).
Main Methods:
- Studied 50 de novo ALL cases previously classified by morphology, cytochemistry, and flow cytometry (FC).
- Performed IH on paraffin-embedded bone marrow trephine biopsy sections using antibodies: myeloperoxidase (MPO), terminal deoxynucleotidyl transferase (TdT), CD10, CD20, CD79a, and CD3.
- Classified cases into 37 pre-B ALL, 10 T ALL, and 3 mature B ALL.
Main Results:
- TdT was highly expressed (82% of ALL cases, 95% of pre-B ALL).
- CD79a (68%) and CD10 (65%) were common in pre-B ALL; CD79a was also positive in B ALL (66%).
- CD20 was positive in mature B ALL (66%) but less so in pre-B ALL (22%). CD3 was positive in T ALL (70%) and negative in others. MPO was negative in all cases.
Conclusions:
- Immunohistochemical staining of bone marrow trephine biopsies is a viable method for diagnosing and immunophenotyping acute lymphoblastic leukemia (ALL).
- IH provides valuable immunophenotypic information, especially when flow cytometry is not accessible or feasible.
Abstract:
Flow cytometry is the preferred method of diagnosing and immunophenotyping acute lymphoblastic leukemia (ALL). However, there are situations in which immunohistochemical staining (IH) of bone marrow trephine biopsy specimens can be used to provide immunophenotypic information. To evaluate the use of IH and to confirm its value in diagnosing and typing of ALL, we studied 50 cases of denovo ALL that were previously classified into pre B, T and B by morphologic, cytochemical and FC methods. Paraffin embedded bone marrow trephine biopsies sections were stained using a panel of antibodies,namely, myeloperoxidase (MPO), terminal deoxynucleotidyl transferase (TdT), CD10, CD20, CD79a, CD3. The cases included 37 pre BALL, 10 T ALL and 3 mature BALL. TdT was the most commonly expressed antibody and was positive in 41 of 50 cases of ALL (82%) and in 95% of pre B ALL cases. CD79a and CD10 were positive in 68% and 65% of pre B ALL cases, respectively. CD79a showed similar positivity in B ALL cases (66%). CD 20 was positive in 66% of mature B ALL cases but less positive in pre B ALL (22%). CD3 was positive in 70% of T ALL cases and negative in other ALL subtypes. All of the cases were negative for MPO. Diagnosis and immunophenotyping of acute lymphoblastic leukemia is possible using immunohistochemical staining of bone marrow trephine biopsies.
More Related Videos
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
06:48In Ovo Xenografting of Patient-Derived Acute Lymphoblastic Leukemia (ALL) Cells (PDX-ALL)
Published on: August 1, 2025